[{"NetIncomeLoss_1_Q1_USD":-42184000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":12000.0,"IncreaseDecreaseInCommodityContractAssetsAndLiabilities_1_Q1_USD":952000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":134829000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-233621000.0,"Depreciation_1_Q1_USD":919000.0,"PaymentsToAcquireInvestments_1_Q1_USD":619320000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":8867000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":40000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":8886886.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2055000.0,"CommonStockSharesIssued_0_Q1_shares":90428554.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":463355000.0,"Assets_0_Q1_USD":771346000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-52000.0,"AssetsCurrent_0_Q1_USD":742434000.0,"ShareBasedCompensation_1_Q1_USD":9671000.0,"InterestIncomeOther_1_Q1_USD":226000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":90197579.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":3060000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":221000.0,"Revenues_1_Q1_USD":952000.0,"ContractWithCustomerAssetNet_0_Q1_USD":8606000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2055000.0,"RestrictedCash_0_Q1_USD":878000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q1_USD":-52000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-811000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":262720000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":22477000.0,"Liabilities_0_Q1_USD":38560000.0,"Investments_0_Q1_USD":463355000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":12735000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-42236000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-1632000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":22127000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesOutstanding_0_Q1_shares":90428554.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q1_shares":11252710.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":52000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":9671000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":46640000.0,"LiabilitiesCurrent_0_Q1_USD":16083000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-75000000.0,"AccountsPayableCurrent_0_Q1_USD":5593000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7753000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-22000.0,"AdditionalPaidInCapital_0_Q1_USD":1179096000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":100000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_1_Q1_USD":386175000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5907000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":263598000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":2055000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-184926000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1_Q1_USD":-52000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"CommonStockValueOutstanding_0_Q1_USD":90000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":952000.0,"OperatingIncomeLoss_1_Q1_USD":-42405000.0,"OtherNonoperatingExpense_1_Q1_USD":5000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":771346000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-446412000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":9671000.0,"OperatingExpenses_1_Q1_USD":43357000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.47,"StockholdersEquity_0_Q1_USD":732786000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":476000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":463343000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-153000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1623000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":30622000.0,"Ticker":"RLAY","CIK":"1812364","name":"RELAY THERAPEUTICS, INC.","OfficialName":"Relay Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3171086334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210513"}]